Mortality among immunocompromised adult patients with acute respiratory failure requiring invasive mechanical ventilation was strongly associated with time to intubation.
Use of pulmonary hypertension-specific therapy may be helpful in selected patients with sarcoidosis-associated pulmonary hypertension and precapillary pulmonary vascular disease.
Patients with systemic sclerosis-associated pulmonary arterial hypertension who were given combination sequential therapy had improved survival rates compared with patients receiving upfront combination or monotherapy.
Fenofibrate may be a valuable adjunct therapy in type 2 diabetes to reduce the burden of gout.
Withdrawal of medication in juvenile idiopathic arthritis prior to 12 months in clinical inactive disease may increase risk of disease flare.
Linoleic acid may be protective against the development of rheumatoid arthritis.
Variables associated with the use of disease-modifying antirheumatic drugs and favorable power Doppler ultrasound response in patients with RA were assessed.
Investigators examined the association between stain use and the risk of rheumatoid arthritis.
Researchers compared 10-year outcomes of 2 cohorts of patients with inflammatory polyarthritis recruited 10 years apart.
Pooled phase 2 and 3 clinical trial data linked baricitinib to increased LDL-C, HDL-C, and triglyceride levels in RA.
